0001144204-16-083000.txt : 20160217
0001144204-16-083000.hdr.sgml : 20160217
20160217142916
ACCESSION NUMBER: 0001144204-16-083000
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160217
DATE AS OF CHANGE: 20160217
EFFECTIVENESS DATE: 20160217
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Knoll Capital Management, LP
CENTRAL INDEX KEY: 0001325083
IRS NUMBER: 133476926
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-11424
FILM NUMBER: 161432723
BUSINESS ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-808-7474
MAIL ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001325083
XXXXXXXX
12-31-2015
12-31-2015
false
Knoll Capital Management, LP
5 East 44th Street
12th floor
New York
NY
10017
13F HOLDINGS REPORT
028-11424
N
Fred Knoll
President
646-590-3960
/s/ Fred Knoll
New York
NY
02-16-2016
0
21
269729
INFORMATION TABLE
2
infotable.xml
Abeona Therapeutics Inc
COM
00289Y107
4569
1359767
SH
SOLE
1359767
0
0
Advaxis Inc.
COM NEW
007624208
2767
275000
SH
SOLE
275000
0
0
Advaxis Inc.
W EXP 07/15/201
007624117
798
112500
SH
SOLE
112500
0
0
Alcobra Ltd
SHS
M2239P109
7004
1115315
SH
SOLE
1115315
0
0
Aldeyra Therapeutics Inc
COM
01438T106
921
135800
SH
SOLE
135800
0
0
Ampio Pharmaceuticals Inc.
COM
03209T109
11859
3388322
SH
SOLE
3388322
0
0
Aptose Biosciences Inc
COM NEW
03835T200
31
11933
SH
SOLE
11933
0
0
Bio Blast Pharma Ltd
SHS
M20156101
1312
338110
SH
SOLE
338110
0
0
Caladrius Biosciences Inc
COM
128058104
600
555781
SH
SOLE
555781
0
0
Cempra Inc
COM
15130J109
5628
180800
SH
SOLE
180800
0
0
Champions Oncology INC
COMM NEW
15870P307
397
111111
SH
SOLE
111111
0
0
Corbus Pharmaceuticals HLDGS
COM
21833P103
4230
2563925
SH
SOLE
2563925
0
0
Evoke Pharma Inc
COM
30049G104
184
55660
SH
SOLE
55660
0
0
Galmed Pharmaceuticals Ltd
SHS
M47238106
495
65000
SH
SOLE
65000
0
0
Keryx Biopharmaceuticals Inc.
COM
492515101
1010
200000
SH
SOLE
200000
0
0
Medivation, Inc.
COM
58501N101
212591
4397838
SH
SOLE
4397838
0
0
Newlink Genetics Corp
COM
651511107
3728
102437
SH
SOLE
102437
0
0
OHR Pharmaceutical Inc
COM NEW
67778H200
1259
205000
SH
SOLE
205000
0
0
Synthetic Biologics Inc.
COM
87164U102
8551
3734149
SH
SOLE
3734149
0
0
Vascular Biologics LTD
COM
96883109
1753
333332
SH
SOLE
333332
0
0
Zosano Pharma Corp
COM
98979H103
42
18600
SH
SOLE
18600
0
0